Search results for: 'distributed data of service'

The Asia-Pacific network security market grew healthily at a YoY growth of 17.5% in Q3 2018. The YoY growth of this quarter was much stronger as compared to the previous second quarter, which grew at 11.8% YoY. Businesses in the region are increasingly focused on the value of consolidation and integration provided by the security vendors to effecti...

Sub-Saharan Africa (SSA) is witnessing a surge migration within the region and to other parts of the world such as North America and Europe. As a continent, Africa had a net migration population of over 11 million in 2015, predominantly economic migration. • This has been instrumental in the growing volume of international remittances flowing into ...

Healthcare expenditure in Malaysia is growing at a higher rate than the expenditure per capita, which translates into better healthcare provision and quality of service in the country. The Malaysian endoscopy devices market is growing under budget constraints that are forcing hospitals to focus on equipment pricing, negotiate better prices, opt fo...

07 Dec 2020  |  North America  |  Frost Radar

Frost Radar™: US Department of Defense Information Technology Market, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

Key Benefits

This research service is a Frost Radar™ that analyzes the relative growth and innovation of prime contractors for the US Department of Defense (DoD) information technology (IT) products and services. This competitive analysis is based on budget requests and representative contracts. Analyses of research, development, test, and evaluation (RDT&E);...

27 Nov 2019  |  North America  |  Market Research

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Infographics

×

Key Issues Addressed

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

11 Feb 2020  |  Asia Pacific  |  Market Research

Commercial MRO Market in Japan, S. Korea, and China, 2019

Commercial MRO Market Spending Hovers Around USD 13.0 Billion among Top-3 Nations of NE Asia in 2019

Infographics

×

This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 3 Northeast Asian nations consisting of China, South Korea, and Japan boasting a combined airline fleet size of close to 5,000 aircraft at the end of 2019. The study focuses on the fleet and MRO spending comparisons among these top 3 N.E. Asian nati...

12 Feb 2020  |  Asia Pacific  |  Market Research

Commercial MRO Market in Southeast Asia, 2019

Commercial MRO Market Hovers Around US$4.7 Billion Among Top 6 ASEAN Nations in 2019

Infographics

×

This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 6 ASEAN nations of Southeast Asia. These countries had a large, combined airline fleet size of close to 1,800 aircraft by the end of 2019. The study focuses on the fleet and MRO spending comparisons among these top 6 ASEAN nations. It further delves...

Volkswagen's (VW) concession of corporate malfeasance in circumventing Environmental Protection Agency (EPA) testing in the US has sent the global automotive industry into a tailspin. This research service examines the fallout from the emission scandal and its impact on the Volkswagen group, as well as the wider automotive ecosystem.

This research service provides a detailed overview and analysis of ten specialty pharmaceutical companies. They have been chosen by taking into account certain critical indicators such as revenues, research and development (R&D) expenditure, current drug pipeline, earnings per share, stock price appreciation, return on investment, and net income.